Gut-targeted nanoparticles deliver specifically targeted antimicrobial peptides against Clostridium perfringens infections

Bocheng Xu,Weike Shaoyong,Lin Wang,Chen Yang,Tingjun Chen,Xiao Jiang,Rong Yan,Zipeng Jiang,Pan Zhang,Mingliang Jin,Yizhen Wang
DOI: https://doi.org/10.1126/sciadv.adf8782
IF: 13.6
2023-09-30
Science Advances
Abstract:Specifically targeted antimicrobial peptides (STAMPs) are novel alternatives to antibiotics, whereas the development of STAMPs for colonic infections is hindered by limited de novo design efficiency and colonic bioavailability. In this study, we report an efficient de novo STAMP design strategy that combines a traversal design, machine learning model, and phage display technology to identify STAMPs against Clostridium perfringens . STAMPs could physically damage C. perfringens , eliminate biofilms, and self-assemble into nanoparticles to entrap pathogens. Further, a gut-targeted engineering particle vaccine (EPV) was used for STAMPs delivery. In vivo studies showed that both STAMP and EPV@STAMP effectively limited C. perfringens infections and then reduced inflammatory response. Notably, EPV@STAMP exhibited stronger protection against colonic infections than STAMPs alone. Moreover, 16 S ribosomal RNA sequencing showed that both STAMPs and EPV@STAMP facilitated the recovery of disturbed gut microflora. Collectively, our work may accelerate the development of the discovery and delivery of precise antimicrobials.
multidisciplinary sciences
What problem does this paper attempt to address?